Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Circulatory System Drugs (Find 426 items)

Circulatory System Drugs

Cibenzoline

(53267-01-9)
The first class of anti-arrhythmic drugs produces anti-arrhythmic effects by inhibiting Na+ influx of cardiomyocytes, and can extend the duration of action potentials, and can also reduce Ca2+ influx. It has the characteristics of the third and fourth types. It is used to reduce and prevent extraventricular and supraventricular contractions, prevent the onset of paroxysmal supraventricular tachycardia, and maintain sinus rhythm after recovery of atrial fibrillation and flutter.

Product List

Request for quotation , get quotes from more suppliers.

Product List

Request for quotation , get quotes from more suppliers.

Nitroglycerin

(55-63-0)
Glyceryl trinitrate (GTN; nitroglycerin) is a representative compound from the organic nitrate ester family. Introduced in 1879, it has been used as a therapeutic agent in the treatment of angina pectoris. In the later part of the nineteenth century, the explosive property of nitroglycerin was discovered, and it then became the active component of dynamite. Glyceryl trinitrate, ethylene glycol dinitrate, and other nitrate esters are commonly used in military and mining explosives. In preparing d

Product List

Request for quotation , get quotes from more suppliers.

Guanoxan

(2165-19-7)
Guanoxan is a sympatholytic drug related to Guanethidine (G815000). Guanoxan is used in the treatment of hypertension.

Product List

Request for quotation , get quotes from more suppliers.

Trandolaprilat

(87679-71-8)
A labeled metabolite of Trandolapril, an antihypertensive.

Product List

Request for quotation , get quotes from more suppliers.

Bepridil

(64706-54-3)
The new calcium antagonists, in order to inhibit the slow channel of calcium ions, selectively expand the coronary arteries, in addition, can inhibit the sodium and potassium ion channels, and thus have the characteristics of class I a, III and IV antiarrhythmic drugs. The half-life is up to 42h. It can be administered once a day. It is well tolerated and has less toxic and side effects. Mainly used for the prevention and treatment of angina pectoris, and can be used for arrhythmia, hypertension

Product List

Request for quotation , get quotes from more suppliers.

Circulatory system drugs are about drugs that have the function of regulating the human circulatory system. The circulatory system is a system of body fluids (including blood, lymph and tissue fluids) and pipes through which circulation flows. Circulatory system drugs mainly include cardiovascular system drugs and diuretics. "Circulatory System Drugs" on ECHEMI covers lipid regulating drugs, angina pectoris drugs, calcium channel blockers, anti-congestive heart failure drugs, antihypertensive drugs, antiarrhythmics drugs, anti shock vasoactive drugs, ace inhibitor, peripheral vasodilators, heart failure treatments and drugs, Anti-atherosclerotic drugs, β-adrenergic receptor blockers and other circulatory system drugs, mainly supply raw materials for such drugs.

Frequently Asked Questions

What are circulatory system drugs used for?

Circulatory system drugs are medications designed to treat conditions affecting the heart and blood vessels. They are commonly used to manage hypertension (high blood pressure), heart failure, arrhythmias, angina, and to prevent blood clots. These drugs help regulate blood flow, reduce cardiac workload, and improve overall cardiovascular function, playing a critical role in both acute and chronic cardiovascular care.

What are the main types of circulatory system medications?

The main types of circulatory system drugs include:1. Antihypertensives (e.g., ACE inhibitors, beta-blockers, calcium channel blockers) for lowering blood pressure.2. Antiarrhythmics to stabilize irregular heart rhythms.3. Vasodilators that widen blood vessels to improve blood flow.4. Anticoagulants and antiplatelets (e.g., warfarin, aspirin) to prevent clot formation.5. Diuretics to reduce fluid buildup and lower blood pressure.Each class targets specific mechanisms within the cardiovascular system to achieve therapeutic effects.

How do I choose a reliable supplier for circulatory system APIs?

To choose a reliable supplier for circulatory system active pharmaceutical ingredients (APIs), consider the following criteria:1. Regulatory compliance—ensure the supplier holds certifications such as GMP, FDA approval, or EMA authorization.2. Quality assurance—verify robust testing protocols, documentation (e.g., COA, DMF), and traceability of raw materials.3. Manufacturing consistency—assess batch-to-batch reproducibility and scalability.4. Technical support and regulatory expertise to assist with global market requirements.Selecting a vetted, experienced API manufacturer minimizes risk and ensures drug safety and efficacy.

What quality standards apply to circulatory system drug intermediates?

Circulatory system drug intermediates must adhere to stringent quality standards to ensure final drug safety and performance. Key standards include compliance with ICH guidelines, GMP (Good Manufacturing Practice), and pharmacopeial specifications (e.g., USP, EP). Impurity profiles, residual solvents, and structural identity must be rigorously controlled. Reputable manufacturers conduct comprehensive analytical testing (HPLC, GC, NMR) and maintain full documentation for regulatory submissions.

Are there common side effects associated with circulatory system medications?

Yes, circulatory system drugs may cause side effects depending on the drug class. For example:- Beta-blockers can lead to fatigue, cold extremities, or bradycardia.- ACE inhibitors may cause a persistent dry cough or hyperkalemia.- Diuretics might result in electrolyte imbalances or dehydration.- Anticoagulants increase bleeding risk.Patients should always use these medications under medical supervision, and healthcare providers monitor for adverse reactions to optimize therapy safety and effectiveness.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.